Fig. 3From: Untargeted LC–MS/MS analysis reveals metabolomics feature of osteosarcoma stem cell response to methotrexateThe measurement of tumorigenic potential in osteosarcoma (OS) and their stem cells. a Proliferation rate of OS and their stem cells was determined by CCK8 assay; b Migration and invasion rate was determined by Matrigel® assay; c Orthotopic xenograft models were performed and at 3 weeks after injection, the tumor volume was measured; d, e Methotrexate cytotoxicity assays were performed by using CCK8 assay and IC50 was estimated with GraphPad Prism for Windows. *compared with their parental OS cells, P < 0.05. SC stem cellBack to article page